Use of sensitivity analysis on a physiologically based pharmacokinetic (PBPK) model for chloroform in rats to determine age-related toxicity.

被引：0
|
作者：
Eklund, CR
Simmons, JE
Evans, MV
机构：
[1] US EPA, PKB, ETD, NHEERL,ORD, Res Triangle Pk, NC 27711 USA
[2] US EPA, HEASD, NERL, ORD, Res Triangle Pk, NC 27711 USA
来源：
TOXICOLOGICAL SCIENCES | 2003年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
883
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [21] Automated framework for global sensitivity analysis for the GastroPlus™ physiologically-based pharmacokinetic model
    Scherholz, Megerle L.
    Wang, Zilong
    Forder, James
    Ierapetritou, Marianthi
    Androulakis, Ioannis
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S40 - S41
  • [22] USE OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ANALYSIS OF ANTIBIOTIC DISTRIBUTION IN TISSUE
    MANUILOV, KK
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 548 - 549
  • [23] Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model
    Hiroaki Iijima
    Hidetoshi Shimizu
    Kazumi Mori-Anai
    Atsuhiro Kawaguchi
    Yoji Mochida
    Toshimasa Yamauchi
    Takashi Kadowaki
    Diabetes Therapy, 2024, 15 : 779 - 780
  • [24] Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across Human Lifetime
    Deepika, Deepika
    Sharma, Raju Prasad
    Schuhmacher, Marta
    Kumar, Vikas
    ENVIRONMENTAL RESEARCH, 2021, 199
  • [25] Global optimization of the Michaelis-Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats
    Evans, Marina V.
    Eklund, Christopher R.
    Williams, David N.
    Sey, Yusupha M.
    Simmons, Jane Ellen
    INHALATION TOXICOLOGY, 2020, 32 (03) : 97 - 109
  • [26] Quantitative analysis of an impact of P-glycoprotein on edoxaban's disposition using a human physiologically based pharmacokinetic (PBPK) model
    Kato, Takafumi
    Mikkaichi, Tsuyoshi
    Yoshigae, Yasushi
    Okudaira, Noriko
    Shimizu, Takako
    Izumi, Takashi
    Ando, Shuichi
    Matsumoto, Yoshiaki
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 597
  • [27] Are rats the appropriate experimental model to understand age-related renal drug metabolism and toxicity?
    Trevisan, Andrea
    Nicolli, Annamaria
    Chiara, Federica
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (12) : 1451 - 1459
  • [28] Visualization-based analysis of the sensitivity and identifiability of closed-chamber and constant-inhalation physiologically based pharmacokinetic (PBPK) models for trichloroethylene.
    King, KR
    Evans, MV
    Harris, TR
    FASEB JOURNAL, 2000, 14 (04): : A169 - A169
  • [29] Dosage Appropriacy Evaluation of Oral Venlafaxine Related to CYP2D6 Genotype Using Physiologically Based Pharmacokinetic (PBPK) Model
    Cho, Changkeun
    FASEB JOURNAL, 2020, 34
  • [30] Sensitivity Analysis of a Physiologically Based Pharmacokinetic Model Used for Treatment Planning in Peptide Receptor Radionuclide Therapy
    Hardiansyah, Deni
    Begum, Nusrat Jihan
    Kletting, Peter
    Mottaghy, Felix M.
    Glatting, Gerhard
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2016, 31 (06) : 217 - 224
12345